Literature DB >> 27246321

[Rational use of antibiotics].

P Walger1.   

Abstract

International and national campaigns draw attention worldwide to the rational use of the available antibiotics. This has been stimulated by the high prevalence rates of drug-resistant pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), a threatening spread of development of resistance in Gram-negative rod-shaped bacteria and the selection of Clostridium difficile with a simultaneous clear reduction in the development of new antibiotics. The implementation of antibiotic stewardship programs aims to maintain their effectiveness by a rational use of the available antibiotics. The essential target of therapy with antibiotics is successful treatment of individual patients with bacterial infections. The optimal clinical treatment results can only be achieved when the toxicity, selection of pathogens and development of resistance are minimized. This article presents the principles of a rational antibiotic therapy.

Entities:  

Keywords:  Adverse effects, antibiotics; Antibiotic Stewardship; Antibiotics; Drug interactions; Drug resistance, microbial

Mesh:

Substances:

Year:  2016        PMID: 27246321     DOI: 10.1007/s00108-016-0071-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  21 in total

Review 1.  Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Authors:  Florian Weissinger; Holger W Auner; Hartmut Bertz; Dieter Buchheidt; Oliver A Cornely; Gerlinde Egerer; Werner Heinz; Meinolf Karthaus; Michael Kiehl; William Krüger; Olaf Penack; Stefan Reuter; Markus Ruhnke; Michael Sandherr; Hans-Jürgen Salwender; Andrew J Ullmann; Dirk T Waldschmidt; Hans H Wolf
Journal:  Ann Hematol       Date:  2012-05-26       Impact factor: 3.673

2.  Inhibition of P-glycoprotein-mediated efflux of digoxin and its metabolites by macrolide antibiotics.

Authors:  Jeff Hughes; Andrew Crowe
Journal:  J Pharmacol Sci       Date:  2010       Impact factor: 3.337

3.  Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin.

Authors:  Benjamin C Gebhart; Brian C Barker; Boaz A Markewitz
Journal:  Pharmacotherapy       Date:  2007-03       Impact factor: 4.705

4.  [S2k-guideline gastrointestinal infectious diseases and Whipple's disease].

Authors:  S Hagel; H-J Epple; G E Feurle; W V Kern; P Lynen Jansen; P Malfertheiner; T Marth; E Meyer; M Mielke; V Moos; L von Müller; J Nattermann; M Nothacker; C Pox; E Reisinger; B Salzberger; H J F Salzer; M Weber; T Weinke; S Suerbaum; A W Lohse; A Stallmach
Journal:  Z Gastroenterol       Date:  2015-05-12       Impact factor: 2.000

5.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

6.  [Management of Adult Community-acquired Pneumonia and Prevention - Update 2016].

Authors:  S Ewig; G Höffken; W V Kern; G Rohde; H Flick; R Krause; S Ott; T Bauer; K Dalhoff; S Gatermann; M Kolditz; S Krüger; J Lorenz; M Pletz; A de Roux; B Schaaf; T Schaberg; H Schütte; T Welte
Journal:  Pneumologie       Date:  2016-02-29

7.  [Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)].

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Anaesthesist       Date:  2010-04       Impact factor: 1.041

8.  [Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia. S-3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy].

Authors:  K Dalhoff; M Abele-Horn; S Andreas; T Bauer; H von Baum; M Deja; S Ewig; P Gastmeier; S Gatermann; H Gerlach; B Grabein; G Höffken; W V Kern; E Kramme; C Lange; J Lorenz; K Mayer; I Nachtigall; M Pletz; G Rohde; S Rosseau; B Schaaf; R Schaumann; D Schreiter; H Schütte; H Seifert; H Sitter; C Spies; T Welte
Journal:  Pneumologie       Date:  2012-12-06

9.  Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study.

Authors:  Michael Fralick; Erin M Macdonald; Tara Gomes; Tony Antoniou; Simon Hollands; Muhammad M Mamdani; David N Juurlink
Journal:  BMJ       Date:  2014-10-30

Review 10.  Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).

Authors:  Olaf Penack; Carolin Becker; Dieter Buchheidt; Maximilian Christopeit; Michael Kiehl; Marie von Lilienfeld-Toal; Marcus Hentrich; Marc Reinwald; Hans Salwender; Enrico Schalk; Martin Schmidt-Hieber; Thomas Weber; Helmut Ostermann
Journal:  Ann Hematol       Date:  2014-04-29       Impact factor: 3.673

View more
  1 in total

1.  Over-the-counter sale of antibiotics during COVID-19 outbreak by community pharmacies in Saudi Arabia: a simulated client study.

Authors:  Hani M J Khojah
Journal:  BMC Health Serv Res       Date:  2022-01-29       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.